The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal solid tumors. With an overall five-year survival rate remaining below 6%, there is an explicit need to search for new molecular targets for therapeutic interventions. We undertook a barcode labelled short-hairpin (shRNA) library scree...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kaistha, Brajesh Pratap (VerfasserIn) , Hackert, Thilo (VerfasserIn) , Strobel, Oliver (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: August 03, 2017
In: OncoTarget
Year: 2017, Jahrgang: 8, Heft: 39, Pages: 66215-66225
ISSN:1949-2553
DOI:10.18632/oncotarget.19882
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.18632/oncotarget.19882
Verlag, kostenfrei, Volltext: http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=19882&pubmed-linkout=1
Volltext
Verfasserangaben:Brajesh P. Kaistha, Anja Krattenmacher, Johannes Fredebohm, Harald Schmidt, Diana Behrens, Miriam Widder, Thilo Hackert, Oliver Strobel, Jörg D. Hoheisel, Thomas M. Gress, Malte Buchholz

MARC

LEADER 00000caa a2200000 c 4500
001 157760749X
003 DE-627
005 20230426230647.0
007 cr uuu---uuuuu
008 180714s2017 xx |||||o 00| ||eng c
024 7 |a 10.18632/oncotarget.19882  |2 doi 
035 |a (DE-627)157760749X 
035 |a (DE-576)50760749X 
035 |a (DE-599)BSZ50760749X 
035 |a (OCoLC)1341013806 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kaistha, Brajesh Pratap  |e VerfasserIn  |0 (DE-588)14061544X  |0 (DE-627)620231629  |0 (DE-576)319121178  |4 aut 
245 1 4 |a The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators  |c Brajesh P. Kaistha, Anja Krattenmacher, Johannes Fredebohm, Harald Schmidt, Diana Behrens, Miriam Widder, Thilo Hackert, Oliver Strobel, Jörg D. Hoheisel, Thomas M. Gress, Malte Buchholz 
264 1 |c August 03, 2017 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 14.07.2018 
520 |a Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal solid tumors. With an overall five-year survival rate remaining below 6%, there is an explicit need to search for new molecular targets for therapeutic interventions. We undertook a barcode labelled short-hairpin (shRNA) library screen in pancreatic cancer cells in order to identify novel genes promoting cancer survival and progression. Among the candidate genes identified in this screen was the deubiquitinase USP5, which subsequent gene expression analyses demonstrated to be significantly upregulated in primary human pancreatic cancer tissues. Using different knockdown approaches, we show that expression of USP5 is essential for the proliferation and survival of pancreatic cancer cells, tested under different 2D and 3D cell culture conditions as well as in in vivo experiments. These growth inhibition effects upon knockdown of USP5 are mediated primarily by the attenuation of G1/S phase transition in the cells, which is accompanied by accumulation of DNA damage, upregulation of p27, and increased apoptosis rates. Since USP5 is overexpressed in cancer tissues, it can thus potentially serve as a new target for therapeutic interventions, especially given the fact that deubiquitinases are currently emerging as new class of attractive drug targets in cancer. 
650 4 |a deubiquitinases 
650 4 |a molecular pathogenesis 
650 4 |a pancreatic cancer 
650 4 |a shRNA barcode library screen 
650 4 |a ubiquitin specific peptidase 
700 1 |a Hackert, Thilo  |d 1971-  |e VerfasserIn  |0 (DE-588)122158512  |0 (DE-627)70579346X  |0 (DE-576)182659208  |4 aut 
700 1 |a Strobel, Oliver  |d 1974-  |e VerfasserIn  |0 (DE-588)123658977  |0 (DE-627)706385101  |0 (DE-576)293812357  |4 aut 
773 0 8 |i Enthalten in  |t OncoTarget  |d [Erscheinungsort nicht ermittelbar] : Impact Journals LLC, 2010  |g 8(2017), 39, Seite 66215-66225  |h Online-Ressource  |w (DE-627)63035975X  |w (DE-600)2560162-3  |w (DE-576)325343764  |x 1949-2553  |7 nnas  |a The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators 
773 1 8 |g volume:8  |g year:2017  |g number:39  |g pages:66215-66225  |g extent:11  |a The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators 
856 4 0 |u http://dx.doi.org/10.18632/oncotarget.19882  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=19882&pubmed-linkout=1  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180714 
993 |a Article 
994 |a 2017 
998 |g 123658977  |a Strobel, Oliver  |m 123658977:Strobel, Oliver  |d 910000  |d 910200  |e 910000PS123658977  |e 910200PS123658977  |k 0/910000/  |k 1/910000/910200/  |p 8 
998 |g 122158512  |a Hackert, Thilo  |m 122158512:Hackert, Thilo  |d 910000  |d 910200  |e 910000PH122158512  |e 910200PH122158512  |k 0/910000/  |k 1/910000/910200/  |p 7 
999 |a KXP-PPN157760749X  |e 3017570312 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Brajesh P. Kaistha, Anja Krattenmacher, Johannes Fredebohm, Harald Schmidt, Diana Behrens, Miriam Widder, Thilo Hackert, Oliver Strobel, Jörg D. Hoheisel, Thomas M. Gress, Malte Buchholz"]},"id":{"eki":["157760749X"],"doi":["10.18632/oncotarget.19882"]},"recId":"157760749X","physDesc":[{"extent":"11 S."}],"origin":[{"dateIssuedDisp":"August 03, 2017","dateIssuedKey":"2017"}],"relHost":[{"recId":"63035975X","physDesc":[{"extent":"Online-Ressource"}],"disp":"The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulatorsOncoTarget","origin":[{"publisher":"Impact Journals LLC","dateIssuedKey":"2010","publisherPlace":"[Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"2010-"}],"pubHistory":["1.2010,Mai -"],"id":{"zdb":["2560162-3"],"issn":["1949-2553"],"eki":["63035975X"]},"part":{"volume":"8","year":"2017","issue":"39","extent":"11","text":"8(2017), 39, Seite 66215-66225","pages":"66215-66225"},"title":[{"title_sort":"OncoTarget","title":"OncoTarget","subtitle":"open access impact journal"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"note":["Gesehen am 16.08.2018"]}],"person":[{"display":"Kaistha, Brajesh Pratap","family":"Kaistha","given":"Brajesh Pratap","role":"aut"},{"display":"Hackert, Thilo","family":"Hackert","role":"aut","given":"Thilo"},{"display":"Strobel, Oliver","role":"aut","given":"Oliver","family":"Strobel"}],"title":[{"title_sort":"deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators","title":"The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 14.07.2018"]} 
SRT |a KAISTHABRADEUBIQUITI0320